Xu C, Fu X, Qin H, Yao K
Front Cell Neurosci. 2024; 18:1499719.
PMID: 39678047
PMC: 11637887.
DOI: 10.3389/fncel.2024.1499719.
Stoccoro A, Coppede F
Biomolecules. 2024; 14(11).
PMID: 39595543
PMC: 11591912.
DOI: 10.3390/biom14111366.
Stoccoro A, Lari M, Migliore L, Coppede F
Epigenomes. 2024; 8(4).
PMID: 39449362
PMC: 11503383.
DOI: 10.3390/epigenomes8040038.
Yu Y, Martins L
Int J Mol Sci. 2024; 25(12).
PMID: 38928008
PMC: 11203557.
DOI: 10.3390/ijms25126302.
Tripathi S, Bhawana
Neurochem Res. 2024; 49(9):2319-2335.
PMID: 38856890
DOI: 10.1007/s11064-024-04167-z.
DNA methylation: The epigenetic mechanism of Alzheimer's disease.
Qin H, Liu J, Fang C, Deng Y, Zhang Y
Ibrain. 2024; 9(4):463-472.
PMID: 38680511
PMC: 11045197.
DOI: 10.1002/ibra.12121.
Epigenetic Changes in Alzheimer's Disease: DNA Methylation and Histone Modification.
De Plano L, Saitta A, Oddo S, Caccamo A
Cells. 2024; 13(8.
PMID: 38667333
PMC: 11049073.
DOI: 10.3390/cells13080719.
PGC-1a mediated mitochondrial biogenesis promotes recovery and survival of neuronal cells from cellular degeneration.
You W, Knoops K, Berendschot T, Benedikter B, Webers C, Reutelingsperger C
Cell Death Discov. 2024; 10(1):180.
PMID: 38632223
PMC: 11024166.
DOI: 10.1038/s41420-024-01953-0.
Mitochondria in Alzheimer's Disease Pathogenesis.
Reiss A, Gulkarov S, Jacob B, Srivastava A, Pinkhasov A, Gomolin I
Life (Basel). 2024; 14(2).
PMID: 38398707
PMC: 10890468.
DOI: 10.3390/life14020196.
Gut microbiota defined epigenomes of Alzheimer's and Parkinson's diseases reveal novel targets for therapy.
Nohesara S, Mostafavi Abdolmaleky H, Thiagalingam S, Zhou J
Epigenomics. 2023; 16(1):57-77.
PMID: 38088063
PMC: 10804213.
DOI: 10.2217/epi-2023-0342.
Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
Paniri A, Hosseini M, Akhavan-Niaki H
Mol Neurobiol. 2023; 61(3):1282-1317.
PMID: 37700216
DOI: 10.1007/s12035-023-03626-y.
Characterization of Mitochondrial DNA Methylation of Alzheimer's Disease in Plasma Cell-Free DNA.
Ding B, Zhang X, Wan Z, Tian F, Ling J, Tan J
Diagnostics (Basel). 2023; 13(14).
PMID: 37510095
PMC: 10378411.
DOI: 10.3390/diagnostics13142351.
Comparison between D-loop methylation and mtDNA copy number in patients with Aicardi-Goutières Syndrome.
Dragoni F, Garau J, Orcesi S, Varesio C, Bordoni M, Scarian E
Front Endocrinol (Lausanne). 2023; 14:1152237.
PMID: 36998476
PMC: 10043473.
DOI: 10.3389/fendo.2023.1152237.
Effects of S-Adenosylmethionine on Cognition in Animals and Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhao Y, Zhang Y, Meng S, Chen B, Dong X, Guo X
J Alzheimers Dis. 2023; 94(s1):S267-S287.
PMID: 36970898
PMC: 10473070.
DOI: 10.3233/JAD-221076.
Epigenetic Changes in Prion and Prion-like Neurodegenerative Diseases: Recent Advances, Potential as Biomarkers, and Future Perspectives.
Hernaiz A, Toivonen J, Bolea R, Martin-Burriel I
Int J Mol Sci. 2022; 23(20).
PMID: 36293477
PMC: 9604074.
DOI: 10.3390/ijms232012609.
Is Mitochondria DNA Variation a Biomarker for AD?.
Gao R, Ma S
Genes (Basel). 2022; 13(10).
PMID: 36292674
PMC: 9601433.
DOI: 10.3390/genes13101789.
Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer's Disease Treatment.
Song Y, Zhu X, Zhang X, Xiong H
Int J Mol Sci. 2022; 23(17).
PMID: 36077101
PMC: 9456144.
DOI: 10.3390/ijms23179703.
mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases.
Shang D, Huang M, Wang B, Yan X, Wu Z, Zhang X
Curr Neuropharmacol. 2022; 21(3):578-598.
PMID: 35950246
PMC: 10207910.
DOI: 10.2174/1570159X20666220810114644.
Blood levels of circulating methionine components in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
Zhao Y, Dong X, Chen B, Zhang Y, Meng S, Guo F
Front Aging Neurosci. 2022; 14:934070.
PMID: 35936764
PMC: 9354989.
DOI: 10.3389/fnagi.2022.934070.
Mitochondrial Epigenetics Regulating Inflammation in Cancer and Aging.
Chatterjee D, Das P, Chakrabarti O
Front Cell Dev Biol. 2022; 10:929708.
PMID: 35903542
PMC: 9314556.
DOI: 10.3389/fcell.2022.929708.